Ｓｉｓｏｍｉｃｉｎネブライザー療法の臨床的検討

DOI

書誌事項

タイトル別名
  • Treatment of sinusitis and laryngitis by aerosolized Sisomicin.

この論文をさがす

抄録

A study was made of the efficacy and safety of Sisomicin (Extramycin: Bayer) nebulizer in 31 patients with sinusitis treated with 25mg twice a week for 4 weeks or longer and 16 patients with laryngitis were treated with the same dose twice a week for 2 weeks or longer.<br>1. The Sisomicin concentration in the blood was 0.08μg/ml or less in all cases after the nebulizer treatment.<br>Accumulation of Sisomicin in the blood was not observed.<br>2. Subjective symptoms were relieved in 74.2% of the patients with sinusitis, objective signs were relieved in 67.7%, bacteria were eradicated in 52%, and the rate of usefulness was 74.2%.<br>3. Subjective symptoms and objective signs were relieved in 100% of the patients with laryngitis, bacteria were eradicated in 77.8%, and the rate of usefulness was 100%.<br>4. No side effects were observed in any of the patients in these experiments.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ